Cachet Pharmaceutical Co., Ltd. (SHE:002462)

Cachet Pharmaceutical Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Operating Revenue	19,953	23,985	29,923	26,220	25,626	23,256
Other Revenue	33.96	33.96	73.25	-	-	-
Revenue	19,987	24,019	29,996	26,220	25,626	23,256
Revenue Growth (YoY)	-25.14%	-19.93%	14.40%	2.32%	10.19%	4.82%
Cost of Revenue	18,653	22,431	28,077	24,116	23,493	21,178
Gross Profit	1,334	1,588	1,919	2,104	2,133	2,078
Selling, General & Admin	702.13	882.78	1,052	1,153	1,088	915.23
Other Operating Expenses	55.8	48.43	50.63	45.8	44.73	40.27
Operating Expenses	921.48	1,026	1,186	1,273	1,159	997.23
Operating Income	412.37	561.8	733.78	831	973.49	1,081
Interest Expense	-99.04	-129.18	-166.35	-188.57	-164.24	-180.8
Interest & Investment Income	19.9	19.48	31.12	22.43	18.66	20.16
Currency Exchange Gain (Loss)	-0.21	-0.21	0.57	0.18	-0.66	-0.37
Other Non Operating Income (Expenses)	-23.16	-27.14	-30.13	-30.96	-12.17	-32.26
EBT Excluding Unusual Items	309.86	424.74	568.99	634.08	815.08	887.48
Impairment of Goodwill	-80.41	-80.41	-40.05	-20.21	-13.71	-76.29
Gain (Loss) on Sale of Investments	-0	0.04	-3.5	-2.63	-0.52	-9.79
Gain (Loss) on Sale of Assets	59.16	201.43	0.85	1.67	0.74	1.28
Asset Writedown	-16.2	-6.14	-0.3	-1.88	-0.21	-0.15
Other Unusual Items	40.72	12.01	29.29	33.88	22.59	11.78
Pretax Income	313.12	551.66	555.28	644.91	823.98	814.31
Income Tax Expense	160.79	229.99	178.75	176.59	222.1	223.4
Earnings From Continuing Operations	152.33	321.67	376.53	468.31	601.88	590.9
Minority Interest in Earnings	-81.3	-161.01	-126.47	-171.38	-248	-273.32
Net Income	71.03	160.67	250.06	296.94	353.88	317.59
Net Income to Common	71.03	160.67	250.06	296.94	353.88	317.59
Net Income Growth	-70.91%	-35.75%	-15.79%	-16.09%	11.43%	-15.53%
Shares Outstanding (Basic)	294	292	291	291	292	291
Shares Outstanding (Diluted)	294	292	291	291	292	291
Shares Change (YoY)	1.01%	0.47%	-0.12%	-0.46%	0.38%	11.60%
EPS (Basic)	0.24	0.55	0.86	1.02	1.21	1.09
EPS (Diluted)	0.24	0.55	0.86	1.02	1.21	1.09
EPS Growth	-71.20%	-36.05%	-15.69%	-15.70%	11.01%	-24.31%
Free Cash Flow	918.04	164.93	1,396	-351.98	666.17	856.88
Free Cash Flow Per Share	3.13	0.56	4.80	-1.21	2.28	2.94
Dividend Per Share	0.170	0.170	0.260	0.310	0.370	0.330
Dividend Growth	-34.62%	-34.62%	-16.13%	-16.22%	12.12%	-17.50%
Gross Margin	6.67%	6.61%	6.40%	8.03%	8.32%	8.94%
Operating Margin	2.06%	2.34%	2.45%	3.17%	3.80%	4.65%
Profit Margin	0.36%	0.67%	0.83%	1.13%	1.38%	1.37%
Free Cash Flow Margin	4.59%	0.69%	4.65%	-1.34%	2.60%	3.69%
EBITDA	402.21	613.16	867.17	989.04	1,114	1,208
EBITDA Margin	2.01%	2.55%	2.89%	3.77%	4.35%	5.19%
D&A For EBITDA	-10.16	51.36	133.39	158.03	140.26	127.12
EBIT	412.37	561.8	733.78	831	973.49	1,081
EBIT Margin	2.06%	2.34%	2.45%	3.17%	3.80%	4.65%
Effective Tax Rate	51.35%	41.69%	32.19%	27.38%	26.96%	27.43%
Revenue as Reported	19,987	24,019	29,996	26,220	25,626	23,256

Source: S&P Global Market Intelligence. Standard template. Financial Sources.